Merrimack Pharmaceuticals (MACK) Stock Analysis
NASDAQHealthcareBiotechnology
What Merrimack Pharmaceuticals does
Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Key metrics
ETFs linked to MACK
Broad-market and Healthcare sector ETFs an investor holding Merrimack Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how MACK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze MACK in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Merrimack Pharmaceuticals?
- Merrimack Pharmaceuticals trades under the ticker MACK on NASDAQ.
- Which exchange is MACK listed on?
- MACK is listed on NASDAQ.
- What sector does Merrimack Pharmaceuticals operate in?
- Merrimack Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze MACK in a portfolio?
- PortView shows MACK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.